Review on fluorinated nucleoside/non-nucleoside FDA-approved antiviral drugs

MMF Ismail, MS Ayoup - RSC advances, 2022 - pubs.rsc.org
FDA-approved antiviral agents represent an important class that has attracted attention in
recent years to combat current and future threats of viral pandemics. Fluorine ameliorates …

Generation and characterization of Japanese encephalitis virus expressing GFP reporter gene for high throughput drug screening

ZR Zhang, HQ Zhang, XD Li, CL Deng, Z Wang, JQ Li… - Antiviral Research, 2020 - Elsevier
Japanese encephalitis virus (JEV), a major cause of Japanese encephalitisis, is an
arbovirus that belongs to the genus Flavivirus of the family Flaviviridae. Currently, there is no …

Emergence of resistance-associated variants during sofosbuvir treatment in chronically infected hepatitis E patients

A Gömer, M Klöhn, M Jagst, MK Nocke, S Pischke… - Hepatology, 2023 - journals.lww.com
Conclusions: In conclusion, viral population dynamics played a critical role during antiviral
treatment. High population diversity during sofosbuvir treatment led to the selection of …

Safety and efficacy of four drug regimens versus standard-of-care for the treatment of symptomatic outpatients with COVID-19: A randomised, open-label, multi-arm …

N Chandiwana, C Kruger, H Johnstone… - …, 2022 - thelancet.com
Background This exploratory study investigated four repurposed anti-infective drug
regimens in outpatients with COVID-19. Methods This phase 2, single centre, randomised …

[HTML][HTML] Cell-line dependent antiviral activity of sofosbuvir against Zika virus

N Mumtaz, LC Jimmerson, LR Bushman, JJ Kiser… - Antiviral research, 2017 - Elsevier
The recent epidemic of Zika virus (ZIKV) in the Americas and its association with fetal and
neurological complications has shown the need to develop a treatment. Repurposing of …

Glycosylated diphyllin as a broad-spectrum antiviral agent against Zika virus

A Martinez-Lopez, M Persaud, MP Chavez, H Zhang… - …, 2019 - thelancet.com
Abstract Background Flaviviruses such as Zika cause sporadic pandemic outbreaks
worldwide. There is an urgent need for anti-Zika virus (ZIKV) drugs to prevent mother-to …

[HTML][HTML] Zika virus overview: transmission, origin, pathogenesis, animal model and diagnosis

D Vue, Q Tang - Zoonoses (Burlington, Mass.), 2021 - ncbi.nlm.nih.gov
Zika virus (ZIKV) was first discovered in 1947 in Uganda. ZIKV did not entice much attention
until Brazil hosted the 2016 Summer Olympics Game, where ZIKV attracted a global …

Development of small-molecule inhibitors against zika virus infection

L Wang, R Liang, Y Gao, Y Li, X Deng… - Frontiers in …, 2019 - frontiersin.org
In recent years, the outbreak of infectious disease caused by Zika virus (ZIKV) has posed a
major threat to global public health, calling for the development of therapeutics to treat ZIKV …

Antibiotic fidaxomicin is an RdRp inhibitor as a potential new therapeutic agent against Zika virus

J Yuan, J Yu, Y Huang, Z He, J Luo, Y Wu, Y Zheng… - BMC medicine, 2020 - Springer
Background Zika virus (ZIKV) infection is a global health problem, and its complications,
including congenital Zika syndrome and Guillain-Barré syndrome, constitute a continued …

In vitro and in vivo models for studying Zika virus biology

LJ Pena, K Miranda Guarines… - Journal of General …, 2018 - microbiologyresearch.org
The emergence and rapid spread of Zika virus (ZIKV) in the Americas has prompted the
development of in vitro and in vivo models to understand several aspects of ZIKV biology …